Jonathan Israel


UK & European Patent Attorney


Jonathan is an associate in the life sciences team at Mathys & Squire. He has previously worked in technology transfer, managing a large patent portfolio arising from a globally top ranked university.

LinkedIn Email

Prior to joining Mathys & Squire as a trainee patent attorney, Jonathan previously worked at the Technology Transfer Office of Imperial College London. He has since qualified as a Chartered UK Patent Attorney and is also a part-qualified European Patent Attorney. Jonathan’s day-to-day practice includes patent prosecution at the European Patent Office (EPO) in the field of life sciences, and involvement in defensive and offensive opposition proceedings before the EPO’s Opposition Divisions and Boards of Appeal.

Jonathan’s technical expertise includes prosecuting European applications in subject matter relating to mRNA vaccines, including COVID vaccines; antibody and gene therapies; molecular diagnostics; and microbiome therapeutics.

Jonathan is a Chartered UK Patent Attorney and part-qualified European Patent Attorney. He has also successfully completed a PGCert in Intellectual Property Law with distinction at Queen Mary University of London.

Jonathan holds a master’s degree in immunology from Imperial College London. His research project was concerned with the role of the IL-33/ST2 axis in the pathogenesis of Idiopathic Pulmonary Fibrosis. Jonathan previously graduated with a first class bachelor’s degree from University College London, his studies covering a broad range of topics within the life sciences.

Jonathan is a student member of the Chartered Institute of Patent Attorneys (CIPA).